Blog

Barbara Domayne-Hayman is an expert in supporting early stage companies in the UK life sciences industry, both as an entrepreneur and now also on the investment side. She has worked extensively in therapeutics and platform technology companies, and more recently in data driven health. Here, Barbara shares some of the insights she has gained from […]

read more

Key challenges faced and solutions implemented when spinning out a company Starting a company will always be daunting, but what specific factors should university spin-outs consider to help the process run smoothly? We interviewed Professor Che Connon, scientific founder of three bio-tech spin-out companies; Atelerix, CellulaREvolution and 3D BioTissues, to gain an expert opinion from a […]

read more

  At this year’s Genesis Conference, Oliver Sexton, Investment Director at UKI2S, will be introducing some of the brightest and best rising stars of the biotech industry. Each company will give a short presentation to inform the audience of its technology, aim and vision, offering a unique insight into how these entrepreneurs could shape our […]

read more

1 2 3 30